Lopinavir Exposure With an Increased Dose During Pregnancy

BACKGROUND: Use of standard adult lopinavir/ritonavir (LPV/RTV) dosing (400/100 mg) during the third trimester of pregnancy results in reduced LPV exposure. The goal of this study was to determine LPV exposure during the third trimester of pregnancy and 2 weeks postpartum with a higher LPV/RTV dose....

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Mirochnick, Mark, Best, Brookie M., Stek, Alice M., Capparelli, Edmund, Hu, Chengcheng, Burchett, Sandra K., Holland, Diane T., Smith, Elizabeth, Gaddipati, Sreedhar, Read, Jennifer S.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2008
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3912695/
https://ncbi.nlm.nih.gov/pubmed/18989231
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0b013e318186edd0
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak